久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/17 | 3,730 | 3,760 | 3,655 | 3,660 | -80 | -2.1% | 183,000 |
2023/04/14 | 3,720 | 3,770 | 3,715 | 3,740 | -90 | -2.3% | 194,000 |
2023/04/13 | 3,805 | 3,845 | 3,780 | 3,830 | +40 | +1.1% | 166,000 |
2023/04/12 | 3,790 | 3,800 | 3,765 | 3,790 | +55 | +1.5% | 81,200 |
2023/04/11 | 3,760 | 3,785 | 3,725 | 3,735 | +5 | +0.1% | 101,000 |
2023/04/10 | 3,765 | 3,780 | 3,715 | 3,730 | -20 | -0.5% | 90,500 |
2023/04/07 | 3,750 | 3,770 | 3,740 | 3,750 | -40 | -1.1% | 83,400 |
2023/04/06 | 3,745 | 3,795 | 3,730 | 3,790 | +30 | +0.8% | 115,800 |
2023/04/05 | 3,855 | 3,855 | 3,745 | 3,760 | -100 | -2.6% | 104,400 |
2023/04/04 | 3,820 | 3,860 | 3,795 | 3,860 | +15 | +0.4% | 143,800 |
2023/04/03 | 3,840 | 3,855 | 3,815 | 3,845 | +65 | +1.7% | 97,200 |
2023/03/31 | 3,780 | 3,795 | 3,750 | 3,780 | +35 | +0.9% | 160,300 |
2023/03/30 | 3,795 | 3,800 | 3,730 | 3,745 | -30 | -0.8% | 83,900 |
2023/03/29 | 3,725 | 3,775 | 3,705 | 3,775 | +85 | +2.3% | 133,500 |
2023/03/28 | 3,725 | 3,730 | 3,670 | 3,690 | ±0 | ±0% | 60,300 |
2023/03/27 | 3,685 | 3,710 | 3,675 | 3,690 | +25 | +0.7% | 104,400 |
2023/03/24 | 3,615 | 3,670 | 3,610 | 3,665 | +20 | +0.5% | 94,600 |
2023/03/23 | 3,635 | 3,650 | 3,605 | 3,645 | -50 | -1.4% | 101,400 |
2023/03/22 | 3,710 | 3,715 | 3,665 | 3,695 | +55 | +1.5% | 144,000 |
2023/03/20 | 3,710 | 3,715 | 3,630 | 3,640 | -90 | -2.4% | 119,600 |
2023/03/17 | 3,720 | 3,740 | 3,700 | 3,730 | +35 | +0.9% | 149,900 |
2023/03/16 | 3,640 | 3,700 | 3,630 | 3,695 | -15 | -0.4% | 121,900 |
2023/03/15 | 3,695 | 3,710 | 3,670 | 3,710 | +40 | +1.1% | 131,400 |
2023/03/14 | 3,660 | 3,690 | 3,595 | 3,670 | -55 | -1.5% | 176,500 |
2023/03/13 | 3,775 | 3,775 | 3,695 | 3,725 | -80 | -2.1% | 134,700 |
2023/03/10 | 3,825 | 3,845 | 3,800 | 3,805 | -75 | -1.9% | 143,600 |
2023/03/09 | 3,795 | 3,880 | 3,790 | 3,880 | +105 | +2.8% | 137,800 |
2023/03/08 | 3,800 | 3,800 | 3,775 | 3,775 | -25 | -0.7% | 91,400 |
2023/03/07 | 3,800 | 3,845 | 3,800 | 3,800 | -35 | -0.9% | 89,400 |
2023/03/06 | 3,815 | 3,835 | 3,785 | 3,835 | +20 | +0.5% | 105,900 |
2023/03/03 | 3,770 | 3,825 | 3,750 | 3,815 | +40 | +1.1% | 126,200 |
2023/03/02 | 3,790 | 3,805 | 3,755 | 3,775 | +10 | +0.3% | 81,800 |
2023/03/01 | 3,800 | 3,805 | 3,755 | 3,765 | -55 | -1.4% | 116,300 |
2023/02/28 | 3,865 | 3,875 | 3,805 | 3,820 | -75 | -1.9% | 117,800 |
2023/02/27 | 3,895 | 3,900 | 3,820 | 3,895 | -35 | -0.9% | 130,900 |
2023/02/24 | 3,920 | 3,945 | 3,895 | 3,930 | +10 | +0.3% | 232,000 |
2023/02/22 | 3,920 | 3,940 | 3,900 | 3,920 | -40 | -1% | 101,800 |
2023/02/21 | 3,930 | 3,975 | 3,930 | 3,960 | +45 | +1.1% | 85,400 |
2023/02/20 | 3,910 | 3,915 | 3,885 | 3,915 | +30 | +0.8% | 69,600 |
2023/02/17 | 3,855 | 3,905 | 3,855 | 3,885 | -10 | -0.3% | 56,200 |
2023/02/16 | 3,905 | 3,950 | 3,885 | 3,895 | ±0 | ±0% | 72,000 |
2023/02/15 | 3,920 | 3,920 | 3,875 | 3,895 | -60 | -1.5% | 74,100 |
2023/02/14 | 3,990 | 4,010 | 3,925 | 3,955 | +25 | +0.6% | 89,100 |
2023/02/13 | 4,000 | 4,000 | 3,905 | 3,930 | -60 | -1.5% | 68,600 |
2023/02/10 | 3,970 | 4,035 | 3,955 | 3,990 | -15 | -0.4% | 99,300 |
2023/02/09 | 4,000 | 4,045 | 3,995 | 4,005 | -5 | -0.1% | 112,000 |
2023/02/08 | 3,950 | 4,025 | 3,950 | 4,010 | +55 | +1.4% | 105,500 |
2023/02/07 | 3,895 | 3,975 | 3,895 | 3,955 | +70 | +1.8% | 108,000 |
2023/02/06 | 3,955 | 3,955 | 3,875 | 3,885 | -30 | -0.8% | 155,500 |
2023/02/03 | 4,000 | 4,005 | 3,880 | 3,915 | -125 | -3.1% | 214,800 |
501~
550
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム